ムラガキ　ヨシヒロ   MURAGAKI Yoshihiro   村垣　善浩    所属   医学部 医学科（東京女子医科大学病院）    職種   客員教授
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
掲載誌名	正式名：Journal of neuro-oncology 略　 称：J Neurooncol ISSNコード：15737373/0167594X
掲載区分	国外
巻・号・頁	148(30),pp.489-500
著者・共著者	SHI Shi Wenyin†*, BLUMENTHAL Deborah T, OBERHEIM-BUSH Nancy Ann, KEBIR Sied, LUKAS Rimas V, MURAGAKI Yoshihiro, ZHU Jay-Jiguang, GLAS Martin
発行年月	2020/07
概要	INTRODUCTION:Tumor Treating Fields (TTFields; antimitotic treatment) delivers low-intensity, intermediate-frequency, alternating electric fields through skin-applied transducer arrays. TTFields (200 kHz) was FDA-approved in glioblastoma (GBM), based on the phase 3 EF-11 (recurrent GBM, rGBM) and EF-14 (newly diagnosed GBM, ndGBM) trials. The most common TTFields-related adverse event (AE) in both trials was array-associated skin irritation. We now report on TTFields-related AEs in the real-world, clinical practice setting
DOI	10.1007/s11060-020-03540-6
PMID	32535723